NAUT Stock Summary and Trading Ideas (Nautilus Biotechnology | NASDAQ:NAUT)

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Nautilus Biotechnology trades on the NASDAQ stock market under the symbol NAUT.

As of November 5, 2026, NAUT stock price declined to $2.15 with 7,162,645 million shares trading.

NAUT has a beta of -1.32, meaning it tends to be less sensitive to market movements. NAUT has a correlation of 0.02 to the broad based SPY ETF.

NAUT has a market cap of $273.60 million. This is considered a Small Cap stock.

Last quarter Nautilus Biotechnology reported $200,000 in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-5,000 and exceeded earnings estimates by $.02.

In the last 3 years, NAUT traded as high as $4.31 and as low as $.62.

The top ETF exchange traded funds that NAUT belongs to (by Net Assets): IWM, VTI, IWN, VXF, VTWO.

NAUT has outperformed the market in the last year with a return of +35.2%, while the SPY ETF gained +9.7%. In the last 3 month period, NAUT beat the market returning +118.2%, while SPY returned -4.7%. However, in the most recent 2 weeks NAUT has underperformed the stock market by returning -20.7%, while SPY returned -5.2%.

NAUT support price is $2.02 and resistance is $2.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NAUT shares will trade within this expected range on the day.